As of 2026-05-27, the Intrinsic Value of Opiant Pharmaceuticals Inc (OPNT) is 20.62 USD. This OPNT valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 20.65 USD, the upside of Opiant Pharmaceuticals Inc is -0.10%.
The range of the Intrinsic Value is 16.34 - 29.94 USD
Based on its market price of 20.65 USD and our intrinsic valuation, Opiant Pharmaceuticals Inc (OPNT) is overvalued by 0.10%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 16.34 - 29.94 | 20.62 | -0.1% |
| DCF (Growth 10y) | 22.89 - 42.71 | 29.18 | 41.3% |
| DCF (EBITDA 5y) | 13.58 - 16.39 | 15.03 | -27.2% |
| DCF (EBITDA 10y) | 18.80 - 23.68 | 21.16 | 2.5% |
| Fair Value | -31.40 - -31.40 | -31.40 | -252.06% |
| P/E | (121.59) - 6.05 | (58.95) | -385.4% |
| EV/EBITDA | (34.06) - 12.44 | (14.07) | -168.1% |
| EPV | 12.18 - 14.83 | 13.50 | -34.6% |
| DDM - Stable | (48.56) - (140.05) | (94.30) | -556.7% |
| DDM - Multi | 7.99 - 18.16 | 11.13 | -46.1% |
| Market Cap (mil) | 108.80 |
| Beta | 0.85 |
| Outstanding shares (mil) | 5.27 |
| Enterprise Value (mil) | 87.18 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.54% |
| Cost of Debt | 7.00% |
| WACC | 9.19% |